Eugene Schneider
Chief Tech/Sci/R&D Officer chez IONIS PHARMACEUTICALS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Actuellement, Eugene Schneider occupe le poste de directeur du développement clinique et de vice-président exécutif chez Ionis Pharmaceuticals, Inc. Le Dr Schneider est également directeur médical et vice-président chargé de la santé comportementale chez Excellus BlueCross BlueShield. Dans le passé, le Dr Schneider a été directeur médical principal chez Biovail Technologies Ltd. et directeur médical principal chez Synageva BioPharma Corp. Il a obtenu un doctorat de l'Université de médecine et de dentisterie du New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/02/2024 | 49 812 ( 0,03% ) | 2 M $ | 31/03/2024 |
Postes actifs de Eugene Schneider
| Sociétés | Poste | Début |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Excellus Health Plan, Inc.
 Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Eugene Schneider
| Sociétés | Poste | Fin |
|---|---|---|
| Biovail Technologies Ltd. | Chief Tech/Sci/R&D Officer | - |
| SYNAGEVA BIOPHARMA CORP | Chief Tech/Sci/R&D Officer | - |
Formation de Eugene Schneider
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Excellus Health Plan, Inc.
Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY. | Health Services |
| Biovail Technologies Ltd. | |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
